Meeting
2024 ASCO Breakthrough
A novel artificial intelligence-enhanced electrochemical method for rapid methylation detection in cfDNA: Advancing multi-cancer early diagnosis.
Authors
Li-Yue Sun
Department of Health Management Centre, Zhongshan Hospital, Fudan University, Shanghai, China
Li-Yue Sun , Xin-Xin Zeng , Yu-Ying Jiang , Ju Shen , Ke-Xin Xian , Hua-Gen Li , Rui-Qi Wang , Fang Wang , Sun-Fang Jiang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Gastrointestinal Cancer,Central Nervous System Tumors,Developmental Therapeutics,Genitourinary Cancer,Quality of Care,Healthcare Equity and Access to Care,Population Health,Viral-Mediated Malignancies
Sub Track
Early Detection and Surveillance
Citation
J Clin Oncol 42, 2024 (suppl 23; abstr 181)
DOI
10.1200/JCO.2024.42.23_suppl.181
Abstract #
181
Poster Bd #
J9
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
GaEsSeer: Early detection of gastric and esophageal cancer by integrating methylation and fragmentomics signatures in cfDNA.
First Author: Yunshi Zhong
Poster
2019 ASCO Annual Meeting
Performance comparison of the methylated BCAT1/IKZF1 ctDNA test (COLVERA) with the CEA assay for detection of recurrent colorectal cancer.
First Author: Erin L. Symonds
Poster
2023 ASCO Breakthrough
A panel of seven protein tumour markers for effective and affordable multi-cancer early detection by artificial intelligence.
First Author: Mao Mao
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A retrospective study of circulating tumor DNA for minimal residual disease detection in the management of colorectal cancer.
First Author: Michael H. Storandt